Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Testing Methods to Increase Lung Cancer Screening Among Quitline Callers

NCT05046951 is registered in ClinicalTrials.gov with Georgetown University as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05046951 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Testing Methods to Increase Lung Cancer Screening Among Quitline Callers
Lead sponsor
Georgetown University
Phase
Phase 3
Overall status
Completed
Start date
May 27, 2021
Completion date
June 30, 2022
Enrollment
298 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

population at risk